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ABSTRACT
Objective: The aim of the study was to monitor the magnitude and trends in antimicrobial resistance through surveillance programs and bacteriological 
diagnostic methods.
Methods: The study research has performed a retrospective observational study for period of 6 months (Dec 2019–June 2020) to determine the 
antimicrobial susceptibility pattern on cultures of various specimens at Vivekanandha Medical Care Hospital. The resultant data were computed in 
Microsoft Excel. Analyses were expressed as the total number, frequencies, and percentage.
Results: A total of 110 culture and sensitivity reports were collected from microbiology departments. Among the culture report, 84% accounted for 
gram-negative and 16% for Gram-positive organisms. Out of eight specimens, 15 different bacteria were identified and the most common bacteria 
were Klebsiella pneumonia (25%), E. coli (14%), Staphylococcus aureus (13%), and Pseudomonas aeruginosa (12%).
Conclusion: The interferences from the present study can help in bridging the gap in future educations, training, and adequate decision-making.
Keywords: Antibiotic, Culture, Sensitivity reports, Microbial resistance.
INTRODUCTION
Antibiotics are essential medicines that combat bacterial infections 
with the aid of disrupting the method essential for bacterial cell growth 
and proliferation. They represent one of mankind’s crucial medical 
inventions saving millions of lives throughout the years. The first 
broad-spectrum antibiotic introduced into the world, Penicillin was 
discovered by Alexander Fleming in 1928. Penicillin has saved and is 
still saving millions of lives worldwide playing a major role in treating 
bacterial diseases and in the creation of today’s pharmaceutical 
industry [1,2]. On receiving the Nobel Prize on 1945, December 11, 
Alexander Fleming has warned regarding the abuses of penicillin 
one may impose on themselves and on others when they are not 
used appropriately, and with this thoughtless behavior comes the 
consequence. Adding to the statement, “The time may come when 
penicillin can be bought by anyone in the shops.”
The genetic ability of resistant microbe to exhibit inhibitory action on 
antibiotics by resistance genes gives rise to the phenomena called anti-
microbial resistance (AMR) [3]. AMR is a severe health issue concern 
with the extreme impact on the global health sector and economy. 
They are the subsequent results of evolution through natural selection 
or we can say antibiotic action. A large part of resistant pathogenic 
organisms in a micro-biosphere is pushed due to human activities, 
consisting of indiscriminate use and misuse of antibiotics in humans, 
veterinary medication, and agriculture [4,5]. At the same time, when 
high concentrations of antibiotics used therapeutically can create an 
environment for resistant mutants challenging minor and primary 
infectious.
Many patients are given a non-specific broad-spectrum medicament 
for an actual or suspected infection which is often not necessary to 
the given condition. Subsequently, determining the resistance patterns 
inside the geographical area will assist in choosing and use of the 
effectiveness of antibiotics.
METHODS
The current research performed an observational retrospective 
study for 6 months (December 2019–June 2020) to determine the 
antimicrobial susceptibility pattern on cultures of various specimens 
collected over 2 years. Data on the identified micro-organisms and their 
antimicrobial susceptibility pattern were obtained from the Clinical 
Microbiology Laboratory of Vivekanandha Medical Care teaching 
Hospital (VMCH). The data regarding culture and sensitivity (C/S) 
were isolated from the different specimens such as pus, blood, wound 
swab, conjunctival, tracheal, pleural fluid, sputum, and urine and were 
analyzed including out-patients (OP) and in-patients (IP). To eliminate 
bias in the collection of research data, the C/S reports were filtered to 
retain only the first isolate of the patient. The report was computed in 
Microsoft Excel and was expressed as proportions and percentages. The 
research protocol was approved by the Institutional Ethical Committee, 
with the approval number SVCP/IEC/JAN/2020/02.
RESULTS
The total 110 culture and sensitivity reports had shown (46.2%) 
significant growth of pathogenic organisms exhibiting resistance to 
either single or multiple antibiotics.
Distribution of bacteria as per Gram-stain
Among the culture reports collected, 84% were Gram-negative 
organisms and 16% accounted for Gram-positive organisms as depicted 
in Fig. 1.
Distribution of identified bacterial pathogens
The number of isolates obtained was higher from urine culture (n=45), 
followed by Pus (n=23), sputum (n=17), tracheal (n=9), and blood 
(n=8). In contrast, the least number of isolates was found in wound 
swab (n=4), ear swab (n=3), and conjunctival (n=1) as represented in 
Table 1.
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Organisms isolated from various samples were Enterococcus, 
Enterobacter baumannii, Streptococcus pneumonia, Proteus, 
Acetobacter, Staphylococcus hominis, Enterobacter kobei, Klebsiella 
oxytoca, Corynebacterium striatum, Pseudomonas aeruginosa, and 
Escherichia coli.
Out of eight specimens, fifteen different bacteria were identified, and 
the most frequently isolated microorganisms were Klebsiella pneumonia 
(n=27), E. coli (n=15), Staphylococcus aureus (n=14), and Pseudomonas 
aeruginosa (n=13) as depicted in Table 1.
In percentile, Klebsiella pneumonia was the most common organism 
isolated with 47%, followed by Escherichia coli (22%), Pseudomonas 
aeruginosa (13%), Acinetobacter baumannii (5%), and Proteus 
mirabilis (4%) in the Gram-negative organisms. Among Gram-positive 
organisms, Staphylococcus aureus (37%), Candida tropicalis (25%), and 
Enterococcus faecalis (15%) were frequently isolated.
As shown in Fig. 2, Klebsiella pneumoniae (n=17) and Escherichia coli 
(n=15) were the most frequent bacteria isolated from the urine culture, 
Staphylococcus aureus (n=10) and Streptococcus pneumoniae (n=6) 
were found from pus and Pseudomonas aeruginosa (n=5) from sputum 
culture. Staphylococcus aureus (n=3) was the most seen organism in the 
blood samples.
Streptococcus pneumoniae (n=1) was the only organism that was 
identified in the conjunctival culture test, likewise Corynebacterium 
striatum (n=2) in-ear swab. Pseudomonas aeruginosa (n=2) was 
majorly seen in wound swab culture. Klebsiella pneumoniae (n=2), 
Candida tropicalis (n=2), and Enterococcus faecalis (n=2) from tracheal 
culture test.
Resistant frequency of bacterial isolates
Among the tested antimicrobials toward Gram-negative and 
Gram-positive organisms, the study showed more resistance to 
ampicillin (n=36) accompanied with co-trimoxazole (n=28), ceftriaxone 
(n=26), and cefixime (n=24). The least resistance was shown by 
tigecycline (n=6), clindamycin (n=4), and cefoperazone (n=2), as 
represented in Tables 2 and 3.
From seven different pharmacological categories, 37 antimicrobial 
agents showed resistance towards various organisms. Third-generation 
cephalosporins (28%) exhibited superior resistance, followed by 
penicillin (27%). Other agents were fluoroquinolones (14%), oral and 
parenteral aminoglycosides (5%), tetracycline (5%), and macrolides 
antibiotics (8%) along with nitrofurantoin, colistin, rifampin, and 
co-trimoxazole.
Table 3 depicts the resistance frequency of bacteria toward anti-microbial 
whereas Table 4 represents the resistance percentile of micro-organisms 
exhibit towards antibiotics. Escherichia coli have shown 53% resistance 
to ciprofloxacin and 47% resistance to ceftriaxone, co-trimoxazole. 
Klebsiella pneumoniae showed higher resistance to Ampicillin by 67%. 
Pseudomonas aeruginosa has shown 33% resistance to co-trimoxazole, 
ceftriaxone, cefixime, and levofloxacin. Whereas, Staphylococcus aureus 
was with the highest resistance to ampicillin at 43%.
DISCUSSION
The research aimed to study the identified organisms and to understand 
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Fig. 2: Organisms in the collected specimens
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(C/S) reports collected from the clinical microbiological laboratory of 
VMCH. As per the results obtained, Gram-negative organisms (GNO) had 
the highest predominance accounting for 84% of total C/S collection, 
and Gram-positive organisms (GPO) with 16%. The predominance of 
GNO in hospital settings is similarly seen in other studies of Mehdinejad 
et al., Ali Shamshad et al., and Melkamu et al. [6-9]. In contrast, other 
studies had reported GPO as the predominant pathogen in studies 
conducted by Kalpesh et al., Gupta, and Karlowsky et al. [10-12]. 
According to studies conducted by Tiwari et al. and Mathai et al. the 
highest rates of Gram-negative bacillary resistance was found in 
India and it is well-known that GNO is more frequently encountered 
in different clinical specimens causing nosocomial infections (sepsis, 
pneumonia, and meningitis) [13,14].
The predominant Genus/Species in Gram-Negative isolates are 
Klebsiella (25%), E. coli (14%), and Pseudomonas species (12%). 
Karlowsky et al., Kalpesh et al., Gupta et al., and Kamga et al. have 
reported a high incidence of Klebsiella and E. coli. [10-12]. Likewise, 
in Gram-positive organisms, Staphylococcus aureus (13%) has shown 
the highest frequency. This report was consistent with the study of 
Bhatia et al., Tiwari et al., Kalpesh et al., and Karlowsky et al. where the 
isolation of the organism was reported [10,12,51,52].
As per the finding, the maximum clinical isolates obtained were 
from urine specimens (45) followed by pus (23), sputum (17), 
and tracheal (9). The result was comparable with the reports of 
Alnamnakani et al. [15].
Table 1: Distribution of identified bacterial pathogens
Type of isolates Type of specimen
Urine Pus Sputum Blood Conjunctival Ear Wound Tracheal
K. pneumonia 17 - 4 2 - - 2 2
E. coli 15 - - - - - - -
P. aeruginosa 3 2 5 - - 1 2 -
Enterococcus 3 - - 1 - - - 2
Candida 5 - 2 - - - - 2
E. bawmanii 1 - - - - - - -
Proteus 1 1 - - - - - 1
Streptococcus pneumonia - 6 1 - 1 - - -
S. aureus - 10 1 3 - - - -
Acetobacter - 1 3 1 - - - 1
S. hominis - 1 - - - - - -
Enterobacter kobei - 2 - - - - - -
Klebsiella oxtoca - - 1 - - - - -
Ampc enterobacter - - - 1 - - - -
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Fig. 3: antibiotic resistance against micro-organism
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K. pneumoniae was found to be the major isolate from urine samples 
and identified etiologic agent following E. coli which was similar to 
the findings of Alnamnakani et al., Bajaj et al., Sheth et al., Javeed et al., 
Beyene et al., Tadesse et al., and Mukhtar et al., other studies conducted 
globally [15,16-21].
Amongst the pus culture samples, Streptococcus pneumonia and 
Staphylococcus aureus were the most common bacterial agents. 
Similarly, studies conducted by Alnamnakani et al. and Tiwari et al. have 
reported Staphylococcus aureus as the most common organism [13,15]. 
Staphylococcus aureus was the most frequently isolated microbe in the 
blood samples collected during the study period. The findings from 
previous studies on Ventricular Associated Pneumonia (VAP), Surgical 
Site Infections (SSI) associated patients, and pediatric populations are 
in agreement with the above data, that is, E. coli, K. pneumoniae, and 
Staphylococcus aureus were the major pathogenic organisms. Beyene 
et al., Tadesse et al., Rao et al., Sandeep et al., Seni et al., Lubega et al., 
Abebe et al., and Alnamnakani et al. [9,15,19,20,25-28]. These reports 
support the current findings that these organisms are known etiologies 
for both community and nosocomial associated infections.
The highest percentage of resistance in Escherichia coli causing infections 
were found to be co-trimoxazole (47%), ceftriaxone (47%), cefixime 
(40%), ampicillin (40%), cefotaxime (40%), and cefazolin (40%) in the 
sample population. The finding analysis of the current study showed 
1st, 3rd, and 4th generation cephalosporin has shown less sensitive 
compared to the 2nd generation cephalosporin. The study findings were 
in line with other reports in Ethiopia and overseas.(40-43) Antibiotics that 
have retained their usefulness and showed the least resistance to the 
Gram-negative isolate; E. coli were gentamycin, piptum, imipenem, and 
nitrofurantoin at 93% and Amikacin at 83%. Comparable data were 
found in the Divyashanthi et al. study [37]. Apart from cephalosporin, 
ciprofloxacin has shown a higher resistance percentile of 53% followed 
by co-trimoxazole (47%), and nalidixic acid (27%) in our study. This 
pattern of resistance was shown by studies conducted by Deep et al., 
Maksum et al., Barai et al., and other researches [37-42].
Klebsiella sp. showed the highest level of resistance to Ampicillin (67%). 
The resistance shown by Klebsiella was also observed in other studies 
conducted by Sheth et al., Javeed et al., and Divyashanthi et al. [17,18,37]. 
Likewise, the sensitivity pattern was seen highest at 93% to 
norfloxacin, nalidixic acid, cefaclor, clindamycin, and tigecycline 
followed by gentamycin (82%), ceftriaxone (68%), co-trimoxazole, 
and ciprofloxacin at 67% similarly cefixime and nitrofurantoin at 70%. 
The sensitivity pattern observed was much higher than the studies 
conducted globally in Gondar, and Ethiopia [9,44].
Findings of the current study showed Klebsiella pneumonia had the 
highest susceptibility rate for levofloxacin (82%), cefotaxime (85%), 
gentamycin (82%), amikacin (85%), ampicillin/sulbactam (89%), 
Table 2: Resistant frequency of gram-negative bacterial isolates
Organism Ampicillin Co-trimoxazole Ceftriaxone Cefixime Ciprofloxacin Levofloxacin Tetracycline Amoxiclav
GNO
E. coli 6 7 7 6 8 2 5 5
K. pneumoniae 18 9 10 8 9 5 6 8
Klebsiella oxytoca 0 0 1 2 0 1 1 1
Enterobacte R 
bawmanii
1 0 0 1 0 0 1 1
Proteus mirabilis 1 1 0 1 1 1 0 0
Pseudomonas 
aeruginosa
1 4 4 4 1 4 0 3
Acenobacterbaumanii 0 2 2 0 0 0 0 1
Enterobacter kobei 0 0 0 0 0 2 0 0
Ampcenterobacter 0 0 1 0 0 0 0 1
Organism Cefuroxime Cefotaxime Cefipime Gentamycyn Cefazolin Piptum Nitrofurantoin Amikacin
GNO
E. coli 2 2 6 1 6 1 1 1
K. pneumoniae 7 4 6 5 7 7 8 4
Klebsiella oxytoca 1 0 0 0 0 0 1 0
Enterobacte R 
bawmanii
1 0 1 0 0 1 1 0
Proteus mirabilis 0 1 1 1 0 1 0 0
Pseudomonas 
aeruginosa
3 3 1 1 1 1 0 1
Acenobacterbaumanii 0 2 2 2 0 0 0 0
Enterobacter kobei 0 0 0 0 0 0 0 0
Ampcenterobacter 1 1 0 0 0 1 0 0
Organism Ampicillin/
sulbactum




E. coli 0 0 0 0 1 1 1
K. pneumoniae 3 0 2 2 2 2 2
Klebsiella oxytoca 0 0 0 0 0 0 0
Enterobacte R 
bawmanii
1 1 0 0 0 0 0
Proteus mirabilis 0 1 1 0 0 0 0
Pseudomonas 
aeruginosa
3 0 3 0 0 0 0
Acenobacterbaumanii 1 0 0 0 0 0 0
Enterobacter kobei 0 0 0 0 0 0 0
Ampcenterobacter 1 0 0 0 1 0 0
73
Asian J Pharm Clin Res, Vol 14, Issue 11, 2021, 69-75
































































































































































































































































































































































































































































































































Asian J Pharm Clin Res, Vol 14, Issue 11, 2021, 69-75
 Rangapriya et al.
tigecycline, clindamycin, cefaclor, nalidixic acid, and norfloxacin at 93%. 
The above finding was relatively higher as compared to other reports 
done in Ethiopia and Gondar [9,44]. Whereas, moderate susceptibility 
was shown by cefexime (70%), tetracycline (78%), amoxyclav (70%), 
cefuroxime (74%), cefepime (78%), cefazolin (74%), piptum (74%), 
and carbapenem (74–78%). The least sensitivity was observed for 
ceftriaxone (63%), co-trimoxazole (67%), and ciprofloxacin (67%).
About 22% of total 14 showed moderate sensitivity towards penicillin 
antibiotic. In addition, 86% of isolates have shown higher susceptibility 
to fluoroquinolones, gentamycin, and ampicillin/sulbactam. The highest 
sensitivity percentile was observed for amikacin and co-trimoxazole 
at 93%
Among the Pseudomonas aeruginosa isolates in the current 
study, aminoglycosides (92%), and ciprofloxacin (92%) showed 
the higher sensitivity. The above result data were in line with 
Divyashanthi et al., Nyambura et al., Sheth et al., and BasantiPathi 
et al. [17,22,37,48]. Likewise, moderate sensitivity pattern were shown 
by co-trimoxazole (69%), ceftriaxone (69%), levofloxacin (69%), 
cefuroxime (77%), cefotaxime (77%), and ampicillin/sulbactam (77%). 
The previous other studies conducted in Ethiopia and overseas had also 
conducted C/S reports on Pseudomonas sp. [33-36].
Antibiotics that had retained their usefulness and showed greater 
susceptibility pattern to these Gram-negative isolates in the study 
were amikacin (83%/85%/92%), gentamicin (93%/82%/92%), 
levofloxacin (87%/82%/69%), piptum (93%/74%/92%), 
cefaclor (93%/93%/92%) against E. coli, Klebsiella, and 
Pseudomonas, respectively. This was similar to the previous study 
reports [17,18,37,46,47].
CONCLUSION
The study was able to observe and provide an epidemiological variation 
in resistance and sensitivity pattern by comparing the previous reports. 
To decrease the rising antibiotic resistance, rational use of antibiotics 
is essential according to the antibiotic resistance pattern of that 
particular institution. For this concern, a regular epidemiological study 
needs to be conducted on C/S isolates to guide the clinicians in the 
selection of the appropriate empirical therapy and switching over to 
the best therapeutic choice based on the data. In addition, study data 
can be used as a baseline for future analysis to establish prescribing 
guidelines, determining new therapies, and improve the focus of 
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